Literature DB >> 6387419

The mode of action of antibody in neutrophil bactericidal activity against highly pathogenic group-B streptococci.

P H Cleat, C R Coid.   

Abstract

An investigation was undertaken into the post-phagocytic action of specific antibody in initiating neutrophil bactericidal activity against highly pathogenic group-B streptococci that survive within these cells. Specific antibody appears to gain access to the interior of the neutrophil and binds to the intracellular bacteria. Activation of Fc receptors on the neutrophil surface is not sufficient to initiate bactericidal activity, but the antibody may utilise the surface Fc receptors to gain access to the ingested organisms. Fusion of the lysosomes with the phagosomes containing the streptococci occurs normally in the cells, and proceeds in both the presence and absence of specific antibody. The organisms are resistant, however, to the microbicidal agents of lysosomes. A significant role is demonstrated for specific antibody in "masking" protective determinants on the bacterial surface during the destruction of these organisms by neutrophils. The relevance of antibody entry into neutrophils in relation to the treatment of bacterial infection is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6387419     DOI: 10.1007/bf02124820

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  15 in total

1.  The effect of specific antiserum on the resistance of Neisseria gonorrhoeae to intracellular killing by phagocytes of human blood.

Authors:  D R Veale; C W Penn; S Sutton; H Smith
Journal:  J Gen Microbiol       Date:  1978-05

2.  An alternative role for specific antibody in neutrophil bactericidal activity against highly pathogenic group B streptococci.

Authors:  P H Cleat; C R Coid
Journal:  Br J Exp Pathol       Date:  1982-08

3.  Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes.

Authors:  P C Leijh; M T van den Barselaar; T L van Zwet; M R Daha; R van Furth
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

4.  Detection of group B streptococcal antibodies in human sera by radioimmunoassay: concentrations of type-specific antibodies in sera of adults and infants infected with group B streptococci.

Authors:  H W Wilkinson
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

5.  Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus.

Authors:  C J Baker; D L Kasper
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

6.  Phagocytic and bactericidal activity of human neutrophils against two isolates of Group B streptococci Type Ic of differing pathogenicity.

Authors:  P H Cleat; C R Coid
Journal:  Br J Exp Pathol       Date:  1981-08

7.  Antibody levels in mothers colonised with group B streptococci during pregnancy and in their newborn infants, as measured by an enzyme linked immunosorbent assay.

Authors:  P H Cleat; J Ross; J R Needham
Journal:  Med Microbiol Immunol       Date:  1980-02       Impact factor: 3.402

8.  Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus.

Authors:  C J Baker; D L Kasper; A Paredes; S Alpert; W M McCormack; D Goroff
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

9.  Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera.

Authors:  G W Fischer; G H Lowell; M H Crumrine; J W Bass
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

10.  Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival.

Authors:  J A Armstrong; P D Hart
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  1 in total

1.  Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide.

Authors:  R D Shahin; J Hamel; M F Leef; B R Brodeur
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.